FGL2 and Hepatitis: Furthermore, the studies show that inhibition of FGL2 improves outcomes to experimental hepatitis and thus provide impetus for generation of reagents to inhibit FGL2 in patients with acute and chronic hepatitis B and C virus infection either alone or in combination with present anti-viral agents.